$1,073,967,938
to FRED HUTCHINSON CANCER CENTER
LEADERSHIP GROUP FOR A GLOBAL HIV VACCINE CLINICAL TRIALS NETWORK
Verbatim from USAspending.gov. Capitalization, abbreviations, and codes are unchanged.
What the model surfaced from this award
Funds the Fred Hutchinson Cancer Center's leadership of a global HIV vaccine clinical trials network, an ongoing effort since 2006.
HIV vaccine development remains a critical global health priority; this 20-year network coordinates international trial infrastructure essential to pandemic preparedness.
Supports clinical trial logistics, laboratory capacity, and international coordination networks across partner institutions and countries.
U.S. leadership in vaccine R&D and clinical trial infrastructure positions America as the global standard-setter for infectious disease countermeasures.
Generated by award_classification v2.1.0 via claude-haiku-4-5-20251001 on 2026-05-17. Cost: $0.002892.
- 2026-05-21HVTN LABORATORY PROGRAM$443.7M
- 2026-05-21LEADERSHIP FOR HIV/AIDS CLINICAL TRIALS NETWORKS; HIV VACCINE TRIALS NETWORK$383.5M
- 2026-05-21CANCER CENTER SUPPORT GRANT (COMPREHENSIVE)$221.9M
- 2026-04-20EARLY DETECTION RESEARCH NETWORK: DATA MANAGEMENT AND COORDINATING CENTER$67.7M
- 2026-04-27IGF::OT::IGF CORE INFRASTRUCTURE SUPPORT FOR SURVEILLANCE, EPIDEMIOLOGY, AND END RESULTS (SEER)$38.3M
- USAspending.gov — all awards for this UEI →
- SAM.gov entity registration →
- Award record ingested from usaspending. Source identifier ASST_NON_UM1AI068614_075.
The Buildout does not edit federal records. Any inaccuracy reflects the upstream source; it will update here when corrected there.